期刊文献+

Toll样受体与梗阻性肾病肾纤维化关系研究进展 被引量:1

原文传递
导出
摘要 梗阻性肾病是泌尿系统常见的疾病之一,而肾间质纤维化是梗阻性肾纤维化进展为终末期肾衰竭的通路,以肾间质中细胞及胶原成分集聚增多、伴有肾小管萎缩或扩张、变形及肾小管和间质毛细血管的丧失为特征.Toll样受体(toll like receptors,TLRs)能够影响梗阻性肾纤维化中上皮-间充质细胞转化以及免疫微环境的调节等过程.随着TLRs及其影响梗阻性肾病肾纤维化机制的研究不断深入,TLRs可能成为预防治疗梗阻性肾病肾纤维化的新靶点,将使梗阻性肾病肾纤维化的防治迈上新的台阶.
作者 陈磊 邵怡
出处 《国际泌尿系统杂志》 2016年第2期298-301,共4页 International Journal of Urology and Nephrology
基金 国家自然科学基金(81200504)
  • 相关文献

参考文献29

  • 1Zhang Q, Raoof M, Chen Y, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury [ J ]. Nature,2010,464 (7285) : 104 - 107.
  • 2Huang H, Evankovich J, Yan W, et al. Endogenous histones func- tion as alarmins in sterile inflammatory liver injury through Toll - like receptor 9 in mice [ J ]. Hepatology ( Baltimore, Md) , 2011 , 54 (3) :999 - 1008.
  • 3Anders H J, Schaefer L. Beyond tissue injury - damage - associated molecular patterns, toll - like receptors, and inflammasomes also drive regeneration and fibrosis[ J]. Journal of the American Society of Nephrology : JASN ,2014 ,25 (7) : 1387 - 1400.
  • 4Takeda K,Kaisho T,Akira S. Toll -like receptors[J]. Annual re- view of immunology ,2003,21:335 - 376.
  • 5Kawai T, Akira S. The role of pattern - recognition receptors in in- nate immunity: update on Toll -like receptors[J]. Nature immu- nology ,2010,11 (5) :373 - 384.
  • 6Takeda K, Kaisho T, Akira S. Toll - like receptors 4 expression and cytokine responses in the human urinary tract mueosa[ J]. Annual review of immunology,2003,21:335 -376.
  • 7Termeer C, Benedix F, Sleeman J, et al. Oligosaccharides of Hyalu- ronan activate dendritic cells via toll - like receptor 4 [ J ]. The Journal of experimental medicine ,2002,195 (1) :99 -111.
  • 8Okamura Y, Watari M, Jerud ES, et al. The extra domain A of fi- brouectin activates Toll - like receptor 4 [ J ]. The Journal of bio- logical chemistry ,2001,276( 13 ) : 10229 - 10233.
  • 9Campbell MT, Hile KL, Zhang H, et al. Toll - like receptor 4 : a novel signaling pathway during renal fibrogenesis[ J]. ,The Journal of surgical research ,2011,168 ( 1 ) :61 - 69.
  • 10Pulskens WP, Rampanelli E, Teske GJ, et al. TLR4 promotes fi- brosis but attenuates tubular damage in progressive renal injury [J]. Journal of the American Society of Nephrology: JASN, 2010,21 (8) :1299 - 1308.

二级参考文献39

  • 1O'Connor W Jr, Zenewicz LA, Flavell RA. The dual nature of T(H)17 cells: shiftingthe focus to function. Nat Immunol 2010; 11: 471-6.
  • 2Thiery JP, Sleeman JP. Complex networks orchestrate epithelialmesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7: 131-42.
  • 3Inazaki K, Kanamaru Y, Kojima Y, Sueyoshi N, Okumura K, Kaneko K, et al. Smad3 deficiency attenuates renal fibrosis, inflammation, and apoptosis after unilateral ureteral obstruction. Kidney Int 2004; 66: 597-604.
  • 4Schaier M, Vorwalder S, Sommerer C, Dikow R, Hug F, Gross ML, et al. Role of FTY720 on M1 and M2 macrophages, lymphocytes, and chemokines in 5/6 nephrectomized rats. Am .I Physiol Renal Physiol 2009; 297: F769-80.
  • 5Conroy H, Marshall NA, Mills KH. TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours. Oncogene 2008; 27: 168-80.
  • 6Eddy AA, Molecular basis of renal fibrosis. Pediatr Nephrol2000; 15: 290-301.
  • 7Wynn TA. Fibrotic disease and the T(H)I/T(H)2 paradigm. Nat Rev Immunol2004; 4: 583-94.
  • 8Wynn TA. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 2007; 117: 524-9.
  • 9Reiman RM, Thompson RW, Feng CG, Hari D, Knight R, Cheever AW, et al. Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity. Infect Immun 2006; 74: 1471-9.
  • 10Weng H, Mertens PR, Gressner AM, Dooley S. IFN-gamma abrogates profibrogenic TGF-beta signaling in liver by targeting expression of inhibitory and receptor Smads. J Hepatol2007; 46: 295-303.

共引文献7

同被引文献22

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部